CIK: 0002102314
Total reported value
$466.5M
Reporting period: 2026-03-31 · Number of holdings: 26
Jones Hill Capital LP disclosed 26 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $466.5M and a quarterly turnover rate of 0.0%.
Browse other institutions with $100M to $1B AUMBrowse other institutions starting with "J"
Jones Hill Capital LP's disclosed holdings carry a Herfindahl concentration index of 0.070 — mathematically equivalent to about 14 equally-sized positions, well below its 26 actual disclosed holdings. That gap points to a strategy built around a small core of high-conviction bets rather than broad diversification.
Position sizes are fairly uniform across the portfolio (a coefficient of variation of 0.92), suggesting a disciplined, rules-based approach to how much capital goes into each idea.
No strong tilt toward either adding to existing winners or initiating outsized new positions was observed in the latest reported quarter.
Sector classification currently covers about 30% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
No holding changes this quarter
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | BMRN | Biomarin Pharmaceutical INC | Stock-Healthcare | 15.36% | — | — | — |
| 2 | VRTX | Vertex Pharmaceuticals INC | Stock-Healthcare | 10.40% | — | — | — |
| 3 | PCVX | Vaxcyte INC | Stock-Other | 8.03% | — | — | — |
| 4 | NUVL | Nuvalent Inc-a | Stock-Other | 6.61% | — | — | — |
| 5 | CAPR | Capricor Therapeutics INC | Stock-Other | 5.93% | — | — | — |
| 6 | 430 | Terns Pharmaceuticals INC | Stock-Other | 5.89% | — | — | — |
| 7 | BCAX | Bicara Therapeutics INC | Stock-Other | 5.37% | — | — | — |
| 8 | ANIP | Ani Pharmaceuticals INC | Stock-Other | 5.25% | — | — | — |
| 9 | RARE | Ultragenyx Pharmaceutical In | Stock-Other | 5.23% | — | — | — |
| 10 | ELVN | Enliven Therapeutics INC | Stock-Other | 4.98% | — | — | — |
| 11 | AMLX | Amylyx Pharmaceuticals INC | Stock-Other | 4.76% | — | — | — |
| 12 | ARGX | Argenx Se - Adr | Stock-Healthcare | 4.07% | — | — | — |
| 13 | FULC | Fulcrum Therapeutics INC | Stock-Other | 2.91% | — | — | — |
| 14 | VIR | Vir Biotechnology INC | Stock-Other | 2.30% | — | — | — |
| 15 | NUVB | Nuvation Bio INC | Stock-Other | 2.19% | — | — | — |
| 16 | ORKA | Oruka Therapeutics INC | Stock-Other | 1.48% | — | — | — |
| 17 | CTNM | Contineum Therapeutics Inc-a | Stock-Other | 1.44% | — | — | — |
| 18 | MANE | Veradermics INC | Stock-Other | 1.37% | — | — | — |
| 19 | TNXP | Tonix Pharmaceuticals Holdin | Stock-Other | 1.33% | — | — | — |
| 20 | GPCR | Structure Therapeutics INC | Stock-Other | 1.04% | — | — | — |
| 21 | TRDA | Entrada Therapeutics INC | Stock-Other | 1.01% | — | — | — |
| 22 | PHVS | Pharvaris N.V. | Stock-Other | 1.01% | — | — | — |
| 23 | TRVI | Trevi Therapeutics INC | Stock-Other | 0.95% | — | — | — |
| 24 | RLMD | Relmada Therapeutics INC | Stock-Other | 0.51% | — | — | — |
| 25 | SLN | Silence Therapeutics Plc-adr | Stock-Other | 0.34% | — | — | — |
| 26 | AVBP | Arrivent Biopharma INC | Stock-Other | 0.23% | — | — | — |
Performance for Q3 2026
+7.3%
Performance Last 4 Quarters
+7.3%
Based on 2 months of available history
Based on 79% of reported portfolio value with available pricing
Not enough data yet to compute personality scores
Not enough sector-mapped data yet
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2026-03-31 | 2026-05-14 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0001730565
Total reported value
$466.4M
21 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0001597857
Total reported value
$466.6M
126 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0001742569
Total reported value
$466.1M
42 stks
2025-09-30
Stale — no recent filing
AUM within 0.1% of this institution
Institutions with overlapping top holdings
CIK 0001855655
Total reported value
$4.9B
35 stks
2026-03-31
2 of the top 5 holdings overlap, including Nuvalent Inc-a
CIK 0002026172
Total reported value
$587.7M
144 stks
2026-03-31
2 of the top 5 holdings overlap, including Vertex Pharmaceuticals INC
CIK 0000019481
Total reported value
$362.5M
450 stks
2026-03-31
1 of the top 5 holdings overlap, including Vertex Pharmaceuticals INC